摘要
为了解河南地区超广谱β-内酰胺酶(ESBLs)耐药基因(TEM,SHV,OXA和CTX—M)在产16S rRNA甲基化酶鸡源大肠杆菌的流行,分别设计特异性引物对2005—2008年在河南地区病鸡的病料中分离保存的158株16S rRNA甲基化酶阳性鸡源大肠杆菌进行聚合酶链式反应扩增。检测结果显示,在158株产16S rRNA甲基化酶鸡大肠杆菌中,TEM,SHV,OXA和CTX—M检出率分别为94.3%,2.5%,62%和47.5%。在5组CTX-M组型中,CTX—M-2组型53株,CTX—M-9组型42株,CTX—M-2&CTX—M-9组型20株。提示ESBLs在河南地区产16S rRNA甲基化酶鸡源大肠杆菌中普遍存在,且以TEM,OXA和CTX—M为主。ESBLs和氨基糖苷类高水平耐药16S rRNA甲基化酶基因同时出现在临床分离株中,加重了兽医临床治疗中抗菌药物选择的困难。
In order to investigate the prevalence of extended spectrum beta - lactamas (ESBLs: TEM, SHV, OXA and CTX - M) among 16S rRNA methylase - producing Escherichia coli strains isolated from dis- eased chickens in Henan Province, 158 16S rRNA methylase -producing E. coli strains isolated from diseased chickens during the years 2005 - 2008 were subjected to PCR for the presence of ESBLs. The results revealed : of 158 16S rRNA methylase-producing E. coil strains, the positive rates for TEM,SHV, OXA and CTX-M were 94.3%, 2.5%, 62% and 47.5%, respectively, suggesting ESBLs were prevalent among 16S rRNA methylase -producing E. coli strains isolated from diseased chickens in Henan Province, with TEM, OXA and CTX - M dominant. Co - prevalence of ESBLs and high level aminoglycoside - resistant 16S rRNA methylase among clinical isolates would certainly aggravate the difficulties in drug choice for treatment in veterinary clinical practice.
出处
《江西农业大学学报》
CAS
CSCD
北大核心
2009年第4期621-624,共4页
Acta Agriculturae Universitatis Jiangxiensis
基金
国家"十一五"科技支撑计划(2006BAK02A03-3)
河南省青年骨干教师资助计划